The possible role of vascular endothelial growth factor (VEGF) in gastric ulcer healing: Effect of sofalcone on VEGF release in vitro

Journal of Clinical Gastroenterology

Volumn 27, Issue SUPPL. 1, 1998, Pages

  Takahashi, Morio ^a,c   Maeda, Shin ^a   Ogura, Keiji ^a   Terano, Akira ^b   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Dokkyo University   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiogenesis; Gastric ulcers; Sofalcone; VEGF

Indexed keywords

ANGIOGENIN; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E2; SCATTER FACTOR; SOFALCONE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ANGIOGENESIS; CONFERENCE PAPER; FIBROBLAST; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN SECRETION; STOMACH ULCER; ULCER HEALING;

ANTI-ULCER AGENTS; CHALCONE; CHALCONES; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; STOMACH ULCER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032429011     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199800001-00029     Document Type: Conference Paper

References (33)

1. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267: 10931-4.
2. Fett JW, Strydom DJ, Lobb RR, et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985;24:5480-6.
3. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987;329: 630-2.
4. Schreiber ME, Winkler ME, Drynck R. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science 1986;232:1250-3.
5. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-71.
6. Ziehe M, Jones J, Gullino PM. Role of prostaglandin E1 and copper in angiogenesis. J Natl Cancer Inst 1982;69:475-82.
7. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocrine Rev 1987;8:95-114.
8. Gimenez-Gallego G, Rodkey J, Bennett C, Rios-Candelore M, DiSalvo J, Thomas K. Brain-derived acidic fibroblast growth factor: complete amino acid sequence and homologies. Science 1985;230:1385-8.
9. Folkman J, Szabo S, Vattay P. Effect of oral administration of bFGF on healing of chronic duodenal ulcers, gastric secretion and acute mucosal lesions in rats [Abstract]. Gastroenterology 1990;98:45.
10. Folkman J, Szabo S, Stovroff M, MacNeil P, Li W, Shing Y. Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 1991;214:414-27.
11. Abraham JA, Whang JL, Tumolo A, et al. Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J 1986;5:2523-8.
12. Jaye M, Howk R, Burgess W, et al. Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. Science 1986;233:541-5.
13. Perlman D, Halvorson HO. A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides. J Mol Biol 1983;167:309-409.
14. Miyazono K, Okabe T, Urabe A, Takata F, Heldin CH. Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 1987;262:4098-103.
15. Connolly DT, Heuvelman DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989;84:1470-8.
16. Favard C. Moukadiri H, Dorey C, Paraloran V, Plouet J. Purification and biological properties of vasculotropin, a new angiogenic cytokine. Biol Cell 1991;73:1-6.
17. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
18. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-91.
19. Johnsson A, Heldin CH, Wasteson A, et al. The c-sis gene encodes a precursor of the B chain of platelet-derived growth factor. EMBO J 1984;3:921-8.
20. Brown LF, Olbricht SM, Berswe B. et al. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol 1995;154:2801-7.
21. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-8.
22. Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986;46:5629-32.
23. Detmar M, Brown L, Claffey K, et al. Overexpression of vascular permeability factor and its receptors in psoriasis. J Exp Med 1994;180:1141-6.
24. Yoshikawa T, Nakamura S, Takahashi S, Naito Y, Kondo M. Effect of sofalcone on gastric mucosal injury induced by ischemia-reperfusion and its antioxidant properties. J Clin Gastroenterol 1993;17:(Suppl 1):S111-5.
25. Kobayashi K, Higuchi K, Arakawa T, Matsumoto T. Nagura H. Effect of sofalcone on localization of 15-hydroxy-prostaglandin dehydrogenase, an enzyme that metabolizes prostaglandin E2, in rat gastric mucosa: an immunohistochemical study. J Clin Gastroenterol 1992;14(Suppl 1):S39-42.
26. Ota S, Takahashi M, Yoshiura K, et al. Antiulcer drugs and gastric prostaglandin E2: an in vitro study. J Clin Gastroenterol 1993;17(Suppl 1):S15-21.
27. Tabata M, Tomomasa T, Itoh K, Morikawa A. Effect of 10% ethanol and sofalcone on prostaglandin E2 content, mucus gel thickness, and experimental ulcers in the stomach of developing rats. Digestion 1996;57:47-53.
28. Takahashi M, Ota S, Hata Y, et al. Hepatocyte growth factor as a key to modulate anti-ulcer actions of prostaglandins in stomach. J Clin Invest 1996;98:2604-11.
29. Takahashi M, Hata Y, Ogura K, et al. Vascular endothelial growth factor may mediate anti-ulcer action of prostaglandins in stomach [Abstract]. Gastroenterology 1997;113:G3647.
30. Takahashi M, Ogura K, Maeda S, et al. Promotors of epithelialization induce expression of vascular endothelial growth factor in human gastric epithelial cells in primary culture. FEBS Lett 1997;418:115-8.
31. Hudson N, Balsitis M, Everitt S, Hawkey CJ. Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal antiinflammatory drugs. Gut 1995;37:191-4.
32. Portovaara L, Kaipainen A, Mustonen T, et al. Vascular endothelial growth factor is induced in response to transforming growth factor-b in fibroblastic and epithelial cells. J Biol Chem 1994;269:6271-4.
33. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-39.